We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week

Journal Scan / Research · March 16, 2020

Adjuvant Chemotherapy in Upper Tract Urothelial Carcinoma

The Lancet Oncology


Additional Info

The Lancet Oncology
Adjuvant Chemotherapy in Upper Tract Urothelial Carcinoma (The POUT Trial): A Phase 3, Open-Label, Randomised Controlled Trial
Lancet Oncol 2020 Mar 05;[EPub Ahead of Print], A Birtle, M Johnson, J Chester, R Jones, D Dolling, RT Bryan, C Harris, A Winterbottom, A Blacker, JWF Catto, P Chakraborti, JL Donovan, PA Elliott, A French, S Jagdev, B Jenkins, FX Keeley, R Kockelbergh, T Powles, J Wagstaff, C Wilson, R Todd, R Lewis, E Hall

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading